Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques
- 570 Downloads
Cannabinoid administration before and after simian immunodeficiency virus (SIV)-inoculation ameliorated disease progression and decreased inflammation in male rhesus macaques. Δ9-tetrahydrocannabinol (Δ9-THC) did not increase viral load in brain tissue or produce additive neuropsychological impairment in SIV-infected macaques. To determine if the neuroimmunomodulation of Δ9-THC involved differential microRNA (miR) expression, miR expression in the striatum of uninfected macaques receiving vehicle (VEH) or Δ9-THC (THC) and SIV-infected macaques administered either vehicle (VEH/SIV) or Δ9-THC (THC/SIV) was profiled using next generation deep sequencing. Among the 24 miRs that were differentially expressed among the four groups, 16 miRs were modulated by THC in the presence of SIV. These 16 miRs were classified into four categories and the biological processes enriched by the target genes determined. Our results indicate that Δ9-THC modulates miRs that regulate mRNAs of proteins involved in 1) neurotrophin signaling, 2) MAPK signaling, and 3) cell cycle and immune response thus promoting an overall neuroprotective environment in the striatum of SIV-infected macaques. This is also reflected by increased Brain Derived Neurotrophic Factor (BDNF) and decreased proinflammatory cytokine expression compared to the VEH/SIV group. Whether Δ9-THC-mediated modulation of epigenetic mechanisms provides neuroprotection in other regions of the brain and during chronic SIV-infection remains to be determined.
KeywordsSIV Cannabinoids Striatum miRNA
This study was supported by National Institutes of Health grants: R01 DA030053 (NIH/NIDA), P60AA09803 (Analytical Core Laboratory LSUHSC Alcohol Research Center) and OD011104 (formerly RR00164). We acknowledge the scientific and technical expertise of John Maxi, graduate student at LSUHSC-NO, in dissecting the striatum from the brains. The authors would like to thank Drs. Ronald S. Veazey and Andrew A. Lackner for their scientific expertise. The authors also acknowledge Maurice Duplantis, Yun Te Lin, Faith R. Schiro and Cecily C. Midkiff for their technical assistance in the study.
- Anderson AM et al (2015) Plasma and cerebrospinal fluid biomarkers predict cerebral injury in HIV-infected individuals on stable combination antiretroviral therapy. J Acquir Immune Defic Syndr. doi: 10.1097/QAI.0000000000000532
- Bachis A, Major EO, Mocchetti I (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J Neurosci: Off J Soc Neurosci 23:5715–5722Google Scholar
- Chan WC, Lin WC (2015) MetaMirClust: discovery and exploration of evolutionarily conserved miRNA. Clusters Methods in Molecular Biol. doi: 10.1007/7651_2015_237
- Cosker KE, Segal RA (2014) Neuronal signaling through endocytosis. Cold Spring Harb Perspect Biol. 6 doi: 10.1101/cshperspect.a020669
- Molina PE et al (2014) Modulation of gut-specific mechanisms by chronic delta(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis. AIDS Res Hum Retrovir 30:567–578. doi: 10.1089/AID.2013.0182 PubMedCentralCrossRefPubMedGoogle Scholar
- SAMSHA (2005) Results from the 2004 National Survey on Druge Use and Health: National Findings. vol NSDUH Series H-36. RockvilleGoogle Scholar
- Zhou L et al (2012) A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 13:677. doi: 10.1186/1471-2164-13-677 PubMedCentralCrossRefPubMedGoogle Scholar